37 vaccines are currently undergoing human trials worldwide.
The race for a COVID-19 vaccine is in full swing.
A total of 37 vaccines are now undergoing human trials, including nine which have moved to the final stage of testing.
The international, high-stakes competition took a turn when Russia announced the first coronavirus vaccine cleared for use on August 11.
"She's feeling well and has a high number of antibodies,” Putin claimed about his daughter, who trialled the so-called "Sputnik V" vaccine.
"We are in close contact with the Russian health authorities, and discussions are going on with respect to possible pre-qualification of the vaccine," said World Health Organisation spokesperson Tarik Jasarevic during a press conference in Geneva on August 12.
Even if it is too early to pick a winner, Euronews collected data to see which countries managed to secure the most doses of the vaccine.
Many countries are still in discussion or reportedly about to strike a deal with pharmaceutical industry giants.
The United States and the European Union appear to be the frontrunners.
On September 9, Brussels said it had secured 200 million doses on behalf of all EU Member States from BioNTech and Pfizer Inc.
The worldwide leading position has come at the cost with the US spending $10 billion (€8.5bn/£7.7bn) for up to 1.3 billion doses.
